Other News To Note
Thursday, May 19, 2011
Seaside Therapeutics Inc., of Cambridge, Mass., announced the online publication of a review paper in ACS Chemical Neuroscience detailing the evolving scientific and drug development landscape for fragile X syndrome.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.